NCT02553603View on ClinicalTrials.gov

The Effect of Growth Hormone Releasing Hormone on Cognitive Function in Individuals With Mild Cognitive Impairment

PHASE1CompletedINTERVENTIONAL
Enrollment

22

Participants

Timeline

Start Date

July 18, 2017

Primary Completion Date

January 17, 2019

Study Completion Date

January 17, 2019

Conditions
Mild Cognitive Impairment
Interventions
DRUG

Growth Hormone Releasing Hormone (GHRH)

Growth Hormone Releasing Hormone (GHRH) 1mg/day for 10 weeks

DRUG

Placebo Growth Hormone Releasing Hormone

Placebo GHRH to be given once daily for 10 weeks

Trial Locations (1)

77555

The University of Texas Medical Branch, Galveston

All Listed Sponsors
lead

The University of Texas Medical Branch, Galveston

OTHER

NCT02553603 - The Effect of Growth Hormone Releasing Hormone on Cognitive Function in Individuals With Mild Cognitive Impairment | Biotech Hunter | Biotech Hunter